- Filed
- Oct 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Oct 18, 2025 | 718.19M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $4.28M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $3.03M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $4.36M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $3.14M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $63.96K |
| Current Assets | Q2 2025 · Sep 30, 2024 | $13.77K |
| Total Assets | Q2 2025 · Mar 31, 2025 | $408.77K |
| Total Assets | Q2 2025 · Sep 30, 2024 | $306.71K |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 422.94M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 422.88M sh |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$63.84K |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $12.72K |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $36.94K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | −$376.33K |
| Net Income restated | Q2 2025 · Mar 31, 2024 | −$745.46K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$337.64K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$654.6K |